Innovation mandate

Scott Gottlieb was sworn in as FDA commissioner with a clear, bipartisan mandate to continue and accelerate regulatory innovations that speed the transformation of scientific progress into medical products and to intensify the participation of patients in regulatory decisions.

Gottlieb will start with a large measure of goodwill among career FDA staff and members of Congress who heaved massive sighs of relief when he was selected for the position over candidates who had denigrated the agency’s civil servants and ridiculed the basic premises of modern medical product regulation. ...